XML 64 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Share Capital (Tables)
12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of the effect of share-based compensation on the statements of operations
   
Year ended
   
Year ended
   
Year ended
 
   
December 31,
   
December 31,
   
December 31,
 
   
2024
   
2023
   
2022
 
   
USD thousands
   
USD thousands
   
USD thousands
 
Research and development
   
401
     
407
     
448
 
General and administrative
   
216
     
1,084
     
2,763
 
                         
Total share-based compensation expenses
   
617
     
1,491
     
3,211
 
Schedule of number and weighted average exercise prices of option
   
Weighted average
exercise price
   
Number
of options
   
Weighted
average
remaining contractual life (in years)
   
Weighted
average
exercise price
   
Number
of options
   
Weighted
average
remaining contractual life
(in years)
 
   
2023
   
2023
   
2023
   
2022
   
2022
   
2022
 
Outstanding at January 1
   
0.33
     
35,191,540
     
7.42
     
0.38
     
27,003,260
     
8.12
 
Exercised
   
-
     
-
     
-
     
0.07
     
(1,970,000
)
   
-
 
Forfeited
   
0.39
     
(20,373,620
)
   
-
     
0.32
     
(1,240,120
)
   
-
 
Granted
   
0.07
     
15,055,180
     
5.86
     
0.16
     
11,398,400
     
7.8
 
                                                 
Outstanding at December 31
   
0.16
     
29,873,100
     
5.99
     
0.33
     
35,191,540
     
7.42
 
 
   
Weighted average
exercise price
   
Number
of options
   
Weighted
average
remaining contractual life (in years)
   
Weighted
average
exercise price
   
Number
of options
   
Weighted
average
remaining contractual life
(in years)
 
   
2024
   
2024
   
2024
   
2023
   
2023
   
2023
 
Outstanding at January 1
   
0.16
     
29,873,100
     
5.99
     
0.33
     
35,191,540
     
7.42
 
Exercised
   
-
     
-
     
-
     
-
     
-
     
-
 
Forfeited
   
0.19
     
(667,820
)
   
-
     
0.39
     
(20,373,620
)
   
-
 
Granted
   
0.03
     
2,845,020
     
8.56
     
0.07
     
15,055,180
     
5.86
 
                                                 
Outstanding at December 31
   
0.15
     
32,050,300
     
7.34
     
0.16
     
29,873,100
     
5.99
 
Schedule of Unvested RSA
   
Number of RSAs
 
RSA
 
2024
 
Unvested at beginning of the year
   
-
 
Granted
   
6,443,900
 
Vested
   
-
 
Forfeited
   
-
 
         
Outstanding at December 31, 2024
   
6,443,900
 
Schedule of assumptions used to calculate the fair value of the options
    2024 grants of Options  
Weighted average share price (in U.S. dollar)(a)
   
0.04
 
Exercise price (in U.S. dollar)
   
0.03-0.05
 
Expected life of options (in years)(b)
   
5.5-6.1
 
Expected volatility(c)
   
89.29%-92.98
%
Risk-free interest rate(d)
   
4.1%-4.5
%
Dividend yield
   
0
%